Annual Accounts Receivable
$32.06 M
+$29.30 M+1060.06%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual accounts receivable is currently $32.06 million, with the most recent change of +$29.30 million (+1060.06%) on 31 December 2023. During the last 3 years, it has risen by +$29.94 million (+1408.89%). ARCT annual accounts receivable is now at all-time high.ARCT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$30.20 M
+$6.11 M+25.39%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly accounts receivable is currently $30.20 million, with the most recent change of +$6.11 million (+25.39%) on 30 September 2024. Over the past year, it has dropped by -$8.02 million (-20.99%). ARCT quarterly accounts receivable is now -67.35% below its all-time high of $92.48 million, reached on 31 March 2023.ARCT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1060.1% | -21.0% |
| 3 y3 years | +1408.9% | +1398.7% |
| 5 y5 years | +615.5% | +1050.4% |
ARCT Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1408.9% | -67.3% | +1398.7% |
| 5 y | 5 years | at high | +1408.9% | -67.3% | +1404.7% |
| alltime | all time | at high | +6580.0% | -67.3% | +6191.5% |
Arcturus Therapeutics Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $30.20 M(+25.4%) |
| June 2024 | - | $24.09 M(-11.0%) |
| Mar 2024 | - | $27.06 M(-15.6%) |
| Dec 2023 | $32.06 M(+1060.1%) | $32.06 M(-16.1%) |
| Sept 2023 | - | $38.22 M(+1265.5%) |
| June 2023 | - | $2.80 M(-97.0%) |
| Mar 2023 | - | $92.48 M(+3246.0%) |
| Dec 2022 | $2.76 M(-17.9%) | $2.76 M(+35.2%) |
| Sept 2022 | - | $2.04 M(-9.0%) |
| June 2022 | - | $2.25 M(-39.1%) |
| Mar 2022 | - | $3.69 M(+9.6%) |
| Dec 2021 | $3.37 M | $3.37 M(+67.1%) |
| Sept 2021 | - | $2.02 M(-6.8%) |
| June 2021 | - | $2.16 M(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $2.01 M(-5.6%) |
| Dec 2020 | $2.13 M(-2.5%) | $2.13 M(-13.2%) |
| Sept 2020 | - | $2.45 M(-13.5%) |
| June 2020 | - | $2.83 M(+20.3%) |
| Mar 2020 | - | $2.35 M(+7.9%) |
| Dec 2019 | $2.18 M(-51.4%) | $2.18 M(-17.0%) |
| Sept 2019 | - | $2.63 M(-54.9%) |
| June 2019 | - | $5.82 M(+30.5%) |
| Mar 2019 | - | $4.46 M(-0.5%) |
| Dec 2018 | $4.48 M(+833.5%) | $4.48 M(+299.0%) |
| Sept 2018 | - | $1.12 M(-18.1%) |
| June 2018 | - | $1.37 M(+185.6%) |
| Dec 2017 | $480.00 K(-86.8%) | $480.00 K(-86.8%) |
| Dec 2016 | $3.63 M | $3.63 M |
FAQ
- What is Arcturus Therapeutics Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual accounts receivable year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly accounts receivable year-on-year change?
What is Arcturus Therapeutics Holdings annual accounts receivable?
The current annual accounts receivable of ARCT is $32.06 M
What is the all time high annual accounts receivable for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual accounts receivable is $32.06 M
What is Arcturus Therapeutics Holdings annual accounts receivable year-on-year change?
Over the past year, ARCT annual accounts receivable has changed by +$29.30 M (+1060.06%)
What is Arcturus Therapeutics Holdings quarterly accounts receivable?
The current quarterly accounts receivable of ARCT is $30.20 M
What is the all time high quarterly accounts receivable for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly accounts receivable is $92.48 M
What is Arcturus Therapeutics Holdings quarterly accounts receivable year-on-year change?
Over the past year, ARCT quarterly accounts receivable has changed by -$8.02 M (-20.99%)